[NYC session] Sell Your Science - Best Practices for Developing an Effective Non-Confidential Pitch Deck

Jun 13 2017https://www.eventbrite.com/e/nyc-session-sell-your-science-best-practices-for-de...

It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for sessions on learning the tricks of the trade in preparing a non-confidential deck and executive summary. Experts of the craft will share practical tips on becoming more effective in communicating your story to Angel investors and VCs, increasing your chances of successful fundraising.

Michelle Hartz | Co-Chair, Golden Seeds
Michelle Hartz is the co-chair of health care sector investments at Golden Seeds, one of the largest angel groups in the US. In this role, she is deeply immersed in screening, analyzing and helping to shepherd Golden Seeds investment opportunities in health tech, bio/pharma, diagnostics and medical devices.
Golden Seeds, one of the nation’s largest and most active angel investment groups in the US, focuses on funding young companies in which women play a powerful role. Our investment thesis rests on extensive research that concludes that gender diverse teams produce better return on equity. By seeking companies where women hold leadership positions and own substantial equity, we are funding companies that are likely to have diverse perspectives that will contribute to ultimate success.
Since 2005, more than 275 Golden Seeds members along with our venture funds have invested over $90 million in more than 85 companies across the country.
Michelle is also the founder of Hartz Consulting, a business advisory firm that specializes in working with companies that need expertise in the public policy and regulatory arenas. She is also an advisor to young companies and entrepreneurs as they navigate through policy issues that impact their businesses. Over the course of her career, Michelle has been an entrepreneur who founded three successful businesses; a senior corporate executive at major companies; a strategic business advisor to the leadership of the Fortune Global 500, public and private companies, venture capital and private equity firms; a private company board member; an advisor and investor in early stage companies, and co-founder of a pioneering biotechnology company.
Michelle began her career with McKinsey & Company and in public accounting. Immediately prior to forming Hartz Consulting, LLC, in 2001, she was a managing director of Powell Tate, which she joined at its inception in 1991. Earlier in her career, she was a senior vice president at Burson-Marsteller, where she was responsible for its health care practice in Washington, D.C., and at the genesis of Bethesda Research Laboratories, a leading biotechnology company that had a successful exit in the earliest years of the biotechnology gold rush.
Michelle is a Phi Beta Kappa graduate of the University of California at Los Angeles, where she earned an M.B.A., M.A., and B.A.
Connect with Michelle:   Connect on LinkedIn

11:30 AM | Registration, Networking and Lunch*
12:00 PM | Presentation
12:45 PM | Q&A
1:00 PM | Program Close
*Light food & beverage provided

Who should attend:
This workshop is ideal for inventors in academic centers and hospitals, and early stage healthcare start-ups in the pharma, medical device, consumer health and digital innovation areas.

There is no cost to attend this workshop, but pre-registration is required.

New York Genome Center
101 6th Ave, 1st floor
New York, NY 10013